"At Birmingham Gastroenterology Associates, we are committed to delivering compassionate, state of the art healthcare of the highest quality to our patients."

During the past decade, Birmingham Gastroenterology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 8 clinical trials were completed, i.e. on average, 266.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Birmingham Gastroenterology Associates" #1 sponsor was "Bausch Health Americas, Inc." with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Shire" with 3 trials sponsored, "Evoke Pharma" with 2 trials sponsored and "Altheus Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Birmingham Gastroenterology Associates" #1 collaborator was "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Birmingham Gastroenterology Associates" are "Ulcerative Colitis" (6 trials), "Hepatitis C, Chronic" (4 trials), "Diabetic Gastroparesis" (2 trials), "Hepatitis C Virus" (2 trials) and "Advanced Fibrosis" (1 trials). Many other conditions were trialed in "Birmingham Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "Birmingham Gastroenterology Associates" are "Drug" (16 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Metoclopramide Nasal Spray" (2 trials), "Placebo Nasal Spray" (2 trials), "Ribavirin" (2 trials) and "Telaprevir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Birmingham Gastroenterology Associates" are 17 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Birmingham Gastroenterology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Birmingham Gastroenterology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Birmingham Gastroenterology Associates, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".